T-helper cell phenotype expression in cutaneous lesions of angioimmunoblastic T-cell lymphoma
Poster May 09, 2018
Nupur Patel BS, John Denigris MD, Tania Mendoza MD, Lubomir Sokol MD, PhD, and Lucia Seminario-Vidal MD, PhD
Angioimmunoblastic T-cell lymphoma (AITL) is a common type of peripheral T-cell lymphoma. AITL can be missed until lymphadenopathy develops in patients initially presenting with skin lesions, as skin biopsy may lack conclusive findings. The expression of follicular helper T-cell (THF) markers in the skin can be an important diagnostic clue. We present a case of AITL with skin lesions positive for CD10 and dim PD1 T-cells, with the purpose of highlighting the potential for diagnosing cutaneous AITL via skin biopsy.
71-year old Caucasian male presented for second opinion of his skin lesions. On exam, there were firm nodules throughout his body with enlarged lymph nodes on bilateral axillae. Skin biopsies demonstrated nodular proliferation of atypical lymphoid cells with perivascular and periadnexal infiltration. Staining revealed more prominent B-cell lymphoproliferative, while limited T-cell infiltrate expressed TFH markers, CD10 and PD1, suggestive of TFH origin. Fine needle aspiration of lymph node revealed an aberrant T cell population. Peripheral blood flow cytometry and bone marrow analyses also identified abnormal T cell population with TFH phenotype. Based on overall findings and pathology, diagnosis of AITL was made.
Our case highlights the extranodal presentation of AITL with cutaneous lesions displaying the TFH phenotype. Although AITL and the presence of TFH markers is generally studied via lymph node biopsy, the disease often presents with prominent skin findings that can be diagnosed via biopsy. Further insight into markers specific for cutaneous AITL may lead to advances in diagnostic strategies and clinical outcomes of AITL.
Characterization of a Type 2 diabetes-associated islet-specific enhancer cluster in STARD10 by genome editing of EndoC-βH1 cellsPoster
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
P450 Induction in Cryopreserved Hepatocytes from PXR and CAR Nuclear Receptor Knock-out RatsPoster
The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that regulate the expression of phase I (cytochrome P450s), phase II metabolizing enzymes and transporter genes in response to xenobiotics, including prescription drugs.READ MORE
Mass Spectrometry: From Imaging to Metabolic NetworksPoster
We show that network analysis of co-localized ions from mass spectrometry imaging data provides a detailed chemo-spatial insight into the metabolic heterogeneity of tumors. Furthermore, module preservation analysis between colorectal cancer patients with and without metastatic recurrence suggests hypotheses on the nature of the different local metabolic pathways.READ MORE